Albireo Pharma
Why Robinhood?
You can watch Albireo Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ALBO
Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat.
ALBO Key Statistics
Stock Snapshot
As of today, Albireo Pharma(ALBO) shares are valued at $44.15. The company's market cap stands at 915.89M, with a P/E ratio of -6.57.
On 2026-03-02, Albireo Pharma(ALBO) stock opened at —, reached a high of —, and a low of —.
The Albireo Pharma(ALBO)'s current trading volume is 0, compared to an average daily volume of 1M.
During the past year, Albireo Pharma(ALBO) stock moved between $16.02 at its lowest and $45.23 at its peak.
During the past year, Albireo Pharma(ALBO) stock moved between $16.02 at its lowest and $45.23 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.